You are here

NewAmsterdam Pharma

NewAmsterdam drug shows ‘unexpected’ signs of protecting the heart in latest study

BioPharma Dive

Tue, 12/10/24 - 10:11 pm

NewAmsterdam Pharma

CETP inhibitors

NewAmsterdam drug cuts cholesterol, but by less than expectations, in phase 3 test

Fierce Biotech

Mon, 07/29/24 - 10:27 am

NewAmsterdam Pharma

clinical trials

EP Vantage

Thu, 03/9/23 - 09:47 am

Cerevel Therapeutics

NewAmsterdam Pharma

Nuvectis Pharma

Roivant Sciences

NewAmsterdam's Amgen castoff cuts LDL cholesterol in phase 2, opening new front in race to market

Fierce Biotech

Tue, 01/17/23 - 10:32 am

NewAmsterdam Pharma

CETP inhibitors

clinical trials

NewAmsterdam Pharma to Merge With SPAC Frazier Lifesciences

Marketwatch

Mon, 07/25/22 - 10:49 am

NewAmsterdam Pharma

Frazier Lifesciences

A much-hyped CV drug failed, repeatedly. Now, investors are betting nearly $200M on one last PhIII bid

Endpoints

Thu, 01/14/21 - 10:45 am

cardiovascular disease

NewAmsterdam Pharma

CETP inhibitors

A new biotech forms to revive Amgen's old heart drug

BioPharma Dive

Thu, 08/27/20 - 10:57 am

NewAmsterdam Pharma